Neutrophil-lymphocyte ratio (NLR) as a predictive biomarker for response to high dose interleukin 2 (HDIL-2) in patients with metastatic renal cell carcinoma (mRCC).

e16087Background: Immunotherapy with HDIL-2 results in long-term survival in some mRCC patients but has significant toxicities. Biomarkers predicting response to therapy are needed to better select...